S&P 500
(0.29%) 5 114.65 points
Dow Jones
(0.37%) 38 380 points
Nasdaq
(0.36%) 15 986 points
Oil
(-1.63%) $82.48
Gas
(5.20%) $2.02
Gold
(0.26%) $2 353.40
Silver
(0.25%) $27.61
Platinum
(3.94%) $958.40
USD/EUR
(-0.21%) $0.933
USD/NOK
(-0.35%) $10.99
USD/GBP
(-0.53%) $0.796
USD/RUB
(1.68%) $93.42

के लिए वास्तविक समय के अद्यतन NeuroMetrix Inc [NURO]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Medical Devices
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 14.14%

अंतिम अद्यतन29 Apr 2024 @ 23:36

1.61% $ 4.51

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 23:36):

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico...

Stats
आज की मात्रा 7 667.00
औसत मात्रा 50 182.00
बाजार मूल्य 8.96M
EPS $0 ( 2024-02-22 )
अगली कमाई की तारीख ( $0 ) 2024-05-01
Last Dividend $1 728.00 ( 2007-03-28 )
Next Dividend $0 ( N/A )
P/E -0.720
ATR14 $0.0400 (0.89%)
Insider Trading
Date Person Action Amount type
2024-04-18 Horowitz Joshua Buy 16 438 Common Stock
2024-04-18 Horowitz Joshua Buy 0 Common Stock
2024-04-18 Horowitz Joshua Sell 0 Common Stock
2024-04-01 Higgins Thomas T Buy 469 Common Stock
2024-04-01 Higgins Thomas T Sell 74 Common Stock
INSIDER POWER
54.21
Last 97 transactions
Buy: 971 558 | Sell: 254 579

NeuroMetrix Inc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

NeuroMetrix Inc वित्तीय

Annual 2023
राजस्व: $5.90M
सकल लाभ: $3.95M (66.89 %)
EPS: $-6.27
FY 2023
राजस्व: $5.90M
सकल लाभ: $3.95M (66.89 %)
EPS: $-6.27
FY 2022
राजस्व: $8.26M
सकल लाभ: $5.75M (69.65 %)
EPS: $-4.90
FY 2021
राजस्व: $8.25M
सकल लाभ: $5.92M (71.75 %)
EPS: $-0.342

Financial Reports:

No articles found.

NeuroMetrix Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

NeuroMetrix Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $1 728.00 2007-03-28
Last Dividend $1 728.00 2007-03-28
Next Dividend $0 N/A
Payout Date 2007-04-13
Next Payout Date N/A
# dividends 1 --
Total Paid Out $1 728.00 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-04-29)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2007 $1.000 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1.0831.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.2981.200-9.95-10.00[0 - 0.3]
returnOnEquityTTM-0.3071.500-4.52-6.78[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM16.810.80010.008.00[1 - 3]
quickRatioTTM14.920.80010.008.00[0.8 - 2.5]
cashRatioTTM1.3961.5003.365.03[0.2 - 2]
debtRatioTTM0.0112-1.5009.81-10.00[0 - 0.6]
interestCoverageTTM52.631.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
freeCashFlowPerShareTTM-4.112.00-2.06-4.11[0 - 20]
debtEquityRatioTTM0.0120-1.5009.95-10.00[0 - 2.5]
grossProfitMarginTTM0.6691.0002.192.19[0.2 - 0.8]
operatingProfitMarginTTM-1.2121.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-25.261.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.2750.800-1.497-1.198[0.5 - 2]
Total Score-0.253

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.0591.000-0.2080[1 - 100]
returnOnEquityTTM-0.3072.50-2.90-6.78[0.1 - 1.5]
freeCashFlowPerShareTTM-4.112.00-1.370-4.11[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-3.992.00-1.330-2.66[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.03611.500-3.570[0.5 - 2]
operatingCashFlowSalesRatioTTM-1.0311.000-10.000[0.1 - 0.5]
Total Score-2.82

NeuroMetrix Inc

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं